Want to join the conversation?
Richard Eastman from Robert W. Baird clarifies on the reason of pronounced weakness in Asia on the after market engine side. $DCI clarified by saying that last year there was a lot of headwind in 4Q15, while there was a bit more of a pick up in 4Q16. Also, $DCI added that the company's after market sales was much more compressed than ever.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?